Aandelen in “Medische Specialiteiten”

Aandeel Datum Koers Evolutie
vlag Xtant Medical Holdings Inc 16/12 0,735 USD
+5,00% 		+5,00%

Nieuws over “Medische Specialiteiten”

17/12 · Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc. · Persbericht

17/12 · Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc. · Persbericht

17/12 · Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc. · Persbericht

17/12 · Inspire Medical (INSP) Crashes Over 32%, "Inspire V" Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5 · Persbericht

17/12 · Atossa Therapeutics Wins 2025 Clinical Trials Arena Research and Development Excellence Award in Precision Endocrine Therapy Category · Persbericht

17/12 · Danaher Schedules Fourth Quarter 2025 Earnings Conference Call · Persbericht

17/12 · Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2025 · Persbericht

17/12 · Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands · Persbericht

16/12 · Investors who lost money with shares of Neogen Corporation (NASDAQ: NEOG) should contact the Shareholders Foundation in connection with Lawsuit · Persbericht

16/12 · Analisten voorspellen enorme groei voor EssilorLuxottica door AI-brillen · Business AM

Key takeaways Een marktleider in luxebrillen is klaar om te profiteren van de bloeiende markt voor AI-brillen. Analisten van Citi – via CNBC – hebben hun ‘buy’-aanbeveling voor EssilorLuxottica, het moederbedrijf van Ray-Ban,...

16/12 · Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM · Persbericht

16/12 · Investors in Inspire Medical Systems, Inc. Should Contact Levi & Korsinsky Before January 5, 2026 to Discuss Your Rights - INSP · Persbericht

16/12 · Zynex Financial Restructuring Puts Company on Path to Long-Term Success · Persbericht

16/12 · Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data to Patients and Surgeons to Help Improve Joint Procedure Recovery · Persbericht

16/12 · Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

15/12 · Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth · Persbericht

15/12 · BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec · Persbericht

15/12 · INSP Shareholder Notice: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut · Persbericht

15/12 · Atossa Therapeutics Presents Four Clinical Trial Updates Highlighting (Z)-Endoxifen Research at the 2025 San Antonio Breast Cancer Symposium · Persbericht

15/12 · Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI · Persbericht

15/12 · Proton Therapy New Standard of Care for Patients with Oropharyngeal Cancer · Persbericht

Mijn selecties